Results 181 to 190 of about 18,841,230 (238)

Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid. [PDF]

open access: yesMediterr J Hematol Infect Dis
Dalgetty M   +6 more
europepmc   +1 more source

Gene Expression and Neuroblastoma Cell Differentiation in Response to Retinoic Acid: Differential Effects of 9-Cis and All-Trans Retinoic Acid

open access: yesEuropean Journal of Cancer, 1995
Retinoic acid has considerable potential for the chemoprevention and chemotherapy of cancer. Neuroblastoma cells differentiate in response to retinoic acid in vitro, an observation that has led to clinical trials using either the 13-cis or all-trans ...
Penny Lovat, A D Pearson, A J Malcolm
exaly   +6 more sources

Hypercalcaemia Due to All-Trans Retinoic Acid

Lancet, The, 1992
Hideki Akiyama   +2 more
exaly   +2 more sources

All Trans Retinoic Acid and Cancer

Immunopharmacology and Immunotoxicology, 2010
All-trans retinoic acid (ATRA) is an active metabolite of vitamin A under the family retinoid. Retinoids, through their cognate nuclear receptors, exert potent effects on cell growth, differentiation and apoptosis, and have significant promise for cancer therapy and chemoprevention.
, Siddikuzzaman   +2 more
openaire   +2 more sources

All-Trans Retinoic Acid and Side-Effects

Lancet, The, 1992
D A Winfield, D A Winfield, C H Toh
exaly   +2 more sources

All-Trans-Retinoic Acid and Pseudotumor Cerebri

Leukemia & Lymphoma, 1996
Pseudotumor cerebri or idiopathic intracranial hypertension is a neurological syndrome characterized by signs and symptoms of intracranial hypertension without clinical and radiological evidence of infective or space occupying lesions. Iatrogenic factors are frequent; in particular, cases of Pseudotumor cerebri associated with all-trans-retinoic acid ...
G, Visani   +3 more
openaire   +2 more sources

Modulation of all-trans retinoic acid pharmacokinetics by liarozole

Cancer Chemotherapy and Pharmacology, 1994
Continuous oral dosing with all-trans retinoic acid (RA) is associated with a progressive decrease in plasma drug concentrations that has been linked to relapse and retinoid resistance in patients with acute promyelocytic leukemia (APL). Since oxidation by cytochrome P-450 enzymes is critical in the catabolism of this drug, we evaluated whether ...
V A, Miller   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy